Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 3.33% | 202.10 | 1.2% | $536.25m | |
| GILD | Gilead Sciences, Inc. | 4.69% | 76.19 | 0.9% | $481.31m | |
| BIIB | Biogen Inc. | 2.83% | 337.71 | 1.3% | $395.55m | |
| CELG | Celgene Corporation | 2.93% | 84.23 | 1.2% | $349.13m | |
| ILMN | Illumina, Inc. | 4.06% | 326.12 | 3.5% | $309.72m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 5.50% | 398.33 | 2.6% | $241.06m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 4.98% | 127.54 | 2.0% | $225.79m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 4.25% | 185.20 | 1.9% | $219.43m | |
| SRPT | Sarepta Therapeutics, Inc. | 5.12% | 138.06 | 16.4% | $179.87m | |
| A | Agilent Technologies, Inc. | 2.80% | 67.47 | 1.5% | $161.89m | |
| BMRN | BioMarin Pharmaceutical Inc. | 6.41% | 105.82 | 4.4% | $144.04m | |
| LGND | Ligand Pharmaceuticals Incorporated | 5.90% | 211.88 | 23.3% | $122.17m | |
| VKTX | Viking Therapeutics, Inc. | 6.74% | 15.16 | 0.9% | $119.61m | |
| NKTR | Nektar Therapeutics | 2.57% | 50.34 | 5.6% | $111.85m | |
| EXAS | Exact Sciences Corporation | 2.93% | 67.70 | 25.3% | $106.04m |
Company Profile
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.